10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $335,899 | -44.8% | 8,143 | -25.3% | 0.00% | -100.0% |
| Q2 2023 | $608,824 | -52.4% | 10,903 | -69.0% | 0.00% | 0.0% |
| Q4 2022 | $1,279,882 | -1.5% | 35,123 | -23.1% | 0.00% | 0.0% |
| Q3 2022 | $1,300,000 | -43.5% | 45,654 | -10.1% | 0.00% | -50.0% |
| Q2 2022 | $2,299,000 | -43.0% | 50,805 | -4.2% | 0.00% | -33.3% |
| Q1 2022 | $4,032,000 | -39.1% | 53,009 | +19.3% | 0.00% | -40.0% |
| Q4 2021 | $6,620,000 | +605.8% | 44,439 | +590.0% | 0.01% | +400.0% |
| Q3 2021 | $938,000 | -48.6% | 6,440 | -30.9% | 0.00% | -50.0% |
| Q2 2021 | $1,824,000 | -54.0% | 9,314 | -57.5% | 0.00% | -50.0% |
| Q1 2021 | $3,965,000 | +16.5% | 21,907 | -8.9% | 0.00% | 0.0% |
| Q4 2020 | $3,403,000 | +372.0% | 24,036 | +315.7% | 0.00% | +300.0% |
| Q3 2020 | $721,000 | +223.3% | 5,782 | +131.5% | 0.00% | – |
| Q2 2020 | $223,000 | -74.5% | 2,498 | -82.2% | 0.00% | -100.0% |
| Q1 2020 | $874,000 | – | 14,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |